Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set

Background Many completed trials of interventions for uncomplicated gallstone disease are not as helpful as they could be due to lack of standardisation across studies, outcome definition, collection and reporting. This heterogeneity of outcomes across studies hampers useful synthesis of primary stu...

Full description

Saved in:
Bibliographic Details
Main Authors: Jane Blazeby, Irfan Ahmed, Rumana Newlands, Miriam Brazzelli, Craig Ramsay, Karen Innes, Bernard Croal, Moira Cruickshank, Mohamed Bekheit
Format: Article
Language:English
Published: BMJ Publishing Group 2021-06-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/11/6/e045568.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846162583918215168
author Jane Blazeby
Irfan Ahmed
Rumana Newlands
Miriam Brazzelli
Craig Ramsay
Karen Innes
Bernard Croal
Moira Cruickshank
Mohamed Bekheit
author_facet Jane Blazeby
Irfan Ahmed
Rumana Newlands
Miriam Brazzelli
Craig Ramsay
Karen Innes
Bernard Croal
Moira Cruickshank
Mohamed Bekheit
author_sort Jane Blazeby
collection DOAJ
description Background Many completed trials of interventions for uncomplicated gallstone disease are not as helpful as they could be due to lack of standardisation across studies, outcome definition, collection and reporting. This heterogeneity of outcomes across studies hampers useful synthesis of primary studies and ultimately negatively impacts on decision making by all stakeholders. Core outcome sets offer a potential solution to this problem of heterogeneity and concerns over whether the ‘right’ outcomes are being measured. One of the first steps in core outcome set generation is to identify the range of outcomes reported (in the literature or by patients directly) that are considered important.Objectives To develop a systematic map that examines the variation in outcome reporting of interventions for uncomplicated symptomatic gallstone disease, and to identify other outcomes of importance to patients with gallstones not previously measured or reported in interventional studies.Results The literature search identified 794 potentially relevant titles and abstracts of which 137 were deemed eligible for inclusion. A total of 129 randomised controlled trials, 4 gallstone disease specific patient-reported outcome measures (PROMs) and 8 qualitative studies were included. This was supplemented with data from 6 individual interviews, 1 focus group (n=5 participants) and analysis of 20 consultations. A total of 386 individual recorded outcomes were identified across the combined evidence: 330 outcomes (which were reported 1147 times) from trials evaluating interventions, 22 outcomes from PROMs, 17 outcomes from existing qualitative studies and 17 outcomes from primary qualitative research. Areas of overlap between the evidence sources existed but also the primary research contributed new, unreported in this context, outcomes.Conclusions This study took a rigorous approach to catalogue and map the outcomes of importance in gallstone disease to enhance the development of the COS ‘long’ list. A COS for uncomplicated gallstone disease that considers the views of all relevant stakeholders is needed.
format Article
id doaj-art-e0bc9c8b24824a9e9a81532c5aefa006
institution Kabale University
issn 2044-6055
language English
publishDate 2021-06-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open
spelling doaj-art-e0bc9c8b24824a9e9a81532c5aefa0062024-11-20T06:00:07ZengBMJ Publishing GroupBMJ Open2044-60552021-06-0111610.1136/bmjopen-2020-045568Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome setJane Blazeby0Irfan Ahmed1Rumana Newlands2Miriam Brazzelli3Craig Ramsay4Karen Innes5Bernard Croal6Moira Cruickshank7Mohamed Bekheit8Division of Surgery, Head and Neck, University Hospitals Bristol NHS Foundation Trust, Bristol, UKPublic health department, Barts and The London NHS Trust, London, UKHealth Services Research Unit, University of Aberdeen Institute of Applied Health Sciences, Aberdeen, UKHealth Services Research Unit, University of Aberdeen Health Services Research Unit, Aberdeen, UKHealth Services Research Unit, University of Aberdeen Health Services Research Unit, Aberdeen, UKHealth Services Research Unit, University of Aberdeen Health Services Research Unit, Aberdeen, UKClinical Biochemistry, NHS Grampian, Aberdeen, UKHealth Services Research Unit, University of Aberdeen, Aberdeen, UKDepartment of Surgery, NHS Grampian, Aberdeen, UKBackground Many completed trials of interventions for uncomplicated gallstone disease are not as helpful as they could be due to lack of standardisation across studies, outcome definition, collection and reporting. This heterogeneity of outcomes across studies hampers useful synthesis of primary studies and ultimately negatively impacts on decision making by all stakeholders. Core outcome sets offer a potential solution to this problem of heterogeneity and concerns over whether the ‘right’ outcomes are being measured. One of the first steps in core outcome set generation is to identify the range of outcomes reported (in the literature or by patients directly) that are considered important.Objectives To develop a systematic map that examines the variation in outcome reporting of interventions for uncomplicated symptomatic gallstone disease, and to identify other outcomes of importance to patients with gallstones not previously measured or reported in interventional studies.Results The literature search identified 794 potentially relevant titles and abstracts of which 137 were deemed eligible for inclusion. A total of 129 randomised controlled trials, 4 gallstone disease specific patient-reported outcome measures (PROMs) and 8 qualitative studies were included. This was supplemented with data from 6 individual interviews, 1 focus group (n=5 participants) and analysis of 20 consultations. A total of 386 individual recorded outcomes were identified across the combined evidence: 330 outcomes (which were reported 1147 times) from trials evaluating interventions, 22 outcomes from PROMs, 17 outcomes from existing qualitative studies and 17 outcomes from primary qualitative research. Areas of overlap between the evidence sources existed but also the primary research contributed new, unreported in this context, outcomes.Conclusions This study took a rigorous approach to catalogue and map the outcomes of importance in gallstone disease to enhance the development of the COS ‘long’ list. A COS for uncomplicated gallstone disease that considers the views of all relevant stakeholders is needed.https://bmjopen.bmj.com/content/11/6/e045568.full
spellingShingle Jane Blazeby
Irfan Ahmed
Rumana Newlands
Miriam Brazzelli
Craig Ramsay
Karen Innes
Bernard Croal
Moira Cruickshank
Mohamed Bekheit
Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
BMJ Open
title Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
title_full Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
title_fullStr Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
title_full_unstemmed Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
title_short Identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease: in-depth analysis to inform the development of a core outcome set
title_sort identification and categorisation of relevant outcomes for symptomatic uncomplicated gallstone disease in depth analysis to inform the development of a core outcome set
url https://bmjopen.bmj.com/content/11/6/e045568.full
work_keys_str_mv AT janeblazeby identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT irfanahmed identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT rumananewlands identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT miriambrazzelli identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT craigramsay identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT kareninnes identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT bernardcroal identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT moiracruickshank identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset
AT mohamedbekheit identificationandcategorisationofrelevantoutcomesforsymptomaticuncomplicatedgallstonediseaseindepthanalysistoinformthedevelopmentofacoreoutcomeset